Form D/A — Sentonix, Inc.
0002039609-25-000001 · filed May 12, 2025
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Pharmaceuticals filings
Offering
- Industry
- Pharmaceuticals
- Exemptions
- 06b
- Reported offering amount
- $10,500,000
- Reported amount sold
- $6,499,590
- Minimum investment
- $10,000
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Sentonix, Inc.
- CIK
- 2039609
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2023
- Address
- 1167 MASSACHUSETTS AVE
ARLINGTON, MA 02476 - Phone
- 617-388-6440
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
John Beaver · Executive OfficerArlington, MA Find on LinkedIn ↗
-
Kenan Turnacioglu · Executive OfficerArlington, MA Find on LinkedIn ↗
-
Jack Hoppin · DirectorArlington, MA Find on LinkedIn ↗
-
Karl Schmidt · Executive OfficerArlington, MA Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗